MALVERN, Pa.
Alliance Pharma (Alliance), a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, has opened its new 20,000-square-foot (1,858-square-meter) bioanalytical laboratory, Alliance Pharma Pty, Ltd., in Brisbane, Australia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221207005138/en/
Alliance CEO, Patrick Bennett, and Australia Site President, Jason Wang, cut the ribbon at the Brisbane laboratory grand opening on December 6. (Photo: Business Wire)
The new Australia facility, which the company announced plans for earlier this summer, includes an expansive lab to provide much-needed small and large molecule bioanalytical services for a region with limited choices for bioanalytical support.
“Alliance Pharma’s expanded presence in Australia affirms our commitment to combining scientific talent and technology to deliver global drug development solutions,” said Alliance CEO, Patrick Bennett. “In this new purpose-built laboratory, our talented teams will use their diverse experience and expertise to provide high-quality bioanalytical services.”
“Our new state-of-the-art science facility in Brisbane will further strengthen our global bioanalytical capabilities. It will allow biotech companies to work with us in Australia in the early phase and then transfer the knowledge on these assays to other regions to support the later development phases. Our objective is to accelerate the growth of our best-in-class portfolio and deliver industry-leading drug development service for our worldwide clients,” said Alliance Pharma Site President, Australia, Jason (Hao) Wang, Ph.D.
About Alliance Pharma
Founded in 2008, Alliance is a contract research organization (CRO) with bioanalytical, DMPK, and CMC testing labs in Malvern, PA, Brisbane, AU, Cambridge, U.K., and Sandwich, U.K. The labs specialize in advanced research services for all drug molecules, cell and gene therapies, and drug metabolism studies to support pharmaceutical and biotechnology companies’ drug discovery and development programs. Alliance’s mission is to build a trusted partnership with our clients to support their successful drug development programs. Our business philosophy is based on a foundation of trust, professional ethics, scientific excellence, and regulatory compliance.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221207005138/en/
CONTACT
John Ryan
Vice President of Commercial Operations
+1 609-273-6062
jryan@alliancepharmaco.com
